The FDA has set a PDUFA target action date of March 29, 2026. “The development of LNTH-2501 underscores our commitment to expanding access to high-quality diagnostic solutions in oncology,” said Brian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback